AVITA Medical Target Price

Analysts' average 12-month price target for AVITA Medical is $9.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.76

Average Target Price

$9.00

16.4% downside

4 analysts in the last 4 months

High: $12 | Low: $6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-28	Lake Street	$12	11.5% upside
2026-08-19	BTIGRyan Zimmerman	$11	2.2% upside
2026-08-07	BTIGRyan Zimmerman	$7	34.9% downside
2026-05-15	Lake Street	$6	44.2% downside
2026-03-26	Northland Securities	$10	7.1% downside
2026-01-16	Lake Street	$3.5	67.5% downside
2025-10-17	Lake StreetFrank Takkinen	$4	62.8% downside
2025-01-08	Lake StreetBrooks O'Neil	$14	30.1% upside
2024-05-14	Piper SandlerMatt O'Brien	$9	16.4% downside

AVITA Medical (RCEL) FAQ

AVITA Medical posts a target price of $9. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $9 for RCEL means covering analysts, on average, see the stock 16.4% downside of $10.76 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for RCEL's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; AVITA Medical's other metric pages and overview cover the third.